Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

N-acetylcysteine in bulimia nervosa--open-label trial.

Guerdjikova AI, Blom TJ, Mori N, McElroy SL.

Eat Behav. 2013 Jan;14(1):87-9. doi: 10.1016/j.eatbeh.2012.11.001. Epub 2012 Nov 19.

PMID:
23265409
2.

Zonisamide in the treatment of bulimia nervosa: an open-label, pilot, prospective study.

Guerdjikova AI, Blom TJ, Martens BE, Keck PE Jr, McElroy SL.

Int J Eat Disord. 2013 Nov;46(7):747-50. doi: 10.1002/eat.22159. Epub 2013 Jul 25.

PMID:
23893331
3.

Memantine in the treatment of binge eating disorder: an open-label, prospective trial.

Brennan BP, Roberts JL, Fogarty KV, Reynolds KA, Jonas JM, Hudson JI.

Int J Eat Disord. 2008 Sep;41(6):520-6. doi: 10.1002/eat.20541.

PMID:
18433015
4.

Subjective binge eating with compensatory behaviors: a variant presentation of bulimia nervosa.

Watson HJ, Fursland A, Bulik CM, Nathan P.

Int J Eat Disord. 2013 Mar;46(2):119-26. doi: 10.1002/eat.22052. Epub 2012 Aug 22.

PMID:
22911884
5.

Importance of size in defining binge eating episodes in bulimia nervosa.

Keel PK, Mayer SA, Harnden-Fischer JH.

Int J Eat Disord. 2001 Apr;29(3):294-301.

PMID:
11262508
6.

Individual differences in negative affect and weekly variability in binge eating frequency.

Zander ME, De Young KP.

Int J Eat Disord. 2014 Apr;47(3):296-301. doi: 10.1002/eat.22222. Epub 2013 Nov 12.

PMID:
24222630
7.

An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.

Lam RW, Lee SK, Tam EM, Grewal A, Yatham LN.

J Clin Psychiatry. 2001 Mar;62(3):164-8.

PMID:
11305701
8.

Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.

McElroy SL, Kotwal R, Hudson JI, Nelson EB, Keck PE.

J Clin Psychiatry. 2004 Jan;65(1):50-6.

PMID:
14744168
9.

Lamotrigine use in patients with binge eating and purging, significant affect dysregulation, and poor impulse control.

Trunko ME, Schwartz TA, Marzola E, Klein AS, Kaye WH.

Int J Eat Disord. 2014 Apr;47(3):329-34. doi: 10.1002/eat.22234. Epub 2013 Dec 16.

PMID:
24343841
10.

Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa.

Keel PK, Wolfe BE, Liddle RA, De Young KP, Jimerson DC.

Arch Gen Psychiatry. 2007 Sep;64(9):1058-66.

PMID:
17768271
11.

Baclofen for binge eating: an open-label trial.

Broft AI, Spanos A, Corwin RL, Mayer L, Steinglass J, Devlin MJ, Attia E, Walsh BT.

Int J Eat Disord. 2007 Dec;40(8):687-91.

PMID:
17647277
12.

Differentiating purging and nonpurging bulimia nervosa and binge eating disorder.

Núñez-Navarro A, Jiménez-Murcia S, Alvarez-Moya E, Villarejo C, Díaz IS, Augmantell CM, Granero R, Penelo E, Krug I, Tinahones FJ, Bulik CM, Fernández-Aranda F.

Int J Eat Disord. 2011 Sep;44(6):488-96. doi: 10.1002/eat.20823. Epub 2010 Sep 24.

PMID:
20872757
13.

Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

McElroy SL, Guerdjikova A, Kotwal R, Welge JA, Nelson EB, Lake KA, Keck PE Jr, Hudson JI.

J Clin Psychiatry. 2007 Mar;68(3):390-8.

PMID:
17388708
14.

Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial.

Guerdjikova AI, McElroy SL, Welge JA, Nelson E, Keck PE, Hudson JI.

Int Clin Psychopharmacol. 2009 May;24(3):150-8. doi: 10.1097/YIC.0b013e328329c7b5.

PMID:
19357528
15.

Investigating the use of CD-Rom CBT for bulimia nervosa and binge eating disorder in an NHS adult outpatient eating disorders service.

Graham L, Walton M.

Behav Cogn Psychother. 2011 Jul;39(4):443-56. doi: 10.1017/S1352465810000688. Epub 2011 Jan 5.

PMID:
21208485
16.

A randomized trial comparing the efficacy of cognitive-behavioral therapy for bulimia nervosa delivered via telemedicine versus face-to-face.

Mitchell JE, Crosby RD, Wonderlich SA, Crow S, Lancaster K, Simonich H, Swan-Kremeier L, Lysne C, Myers TC.

Behav Res Ther. 2008 May;46(5):581-92. doi: 10.1016/j.brat.2008.02.004. Epub 2008 Mar 10.

17.

Facets of negative affect prior to and following binge-only, purge-only, and binge/purge events in women with bulimia nervosa.

Berg KC, Crosby RD, Cao L, Peterson CB, Engel SG, Mitchell JE, Wonderlich SA.

J Abnorm Psychol. 2013 Feb;122(1):111-8. doi: 10.1037/a0029703. Epub 2012 Sep 17.

18.

High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial.

Guerdjikova AI, McElroy SL, Kotwal R, Welge JA, Nelson E, Lake K, Alessio DD, Keck PE Jr, Hudson JI.

Hum Psychopharmacol. 2008 Jan;23(1):1-11.

PMID:
18058852
19.

The natural course of bulimia nervosa and binge eating disorder in young women.

Fairburn CG, Cooper Z, Doll HA, Norman P, O'Connor M.

Arch Gen Psychiatry. 2000 Jul;57(7):659-65.

PMID:
10891036
20.

A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.

McElroy SL, Guerdjikova AI, Blom TJ, Crow SJ, Memisoglu A, Silverman BL, Ehrich EW.

Int J Eat Disord. 2013 Apr;46(3):239-45. doi: 10.1002/eat.22114. Epub 2013 Feb 5.

PMID:
23381803
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk